Pharmaceuticals Related News

Intrexon Responds to Short-Sellers’ Report

Holders of Intrexon Corporation stock are watching their portfolios carefully in wake of the anonymous publication last Thursday of a short-seller report that alleges the company’s technology is less cutting-edge than it claims and that its revenues are exaggerated. On [...]

Eli Lilly to Acquire ‘Smart Insulin’ Company Glycostasis, Inc

Eli Lilly and Company are acquiring Glycostasis, Inc., a startup aiming to create “smart insulin.” Seattle-based Glycostasis, founded by CEO Dr. John Mulligan, was incubated by Pacific Northwest Diabetes Research Institute (PNDRI), and later attracted Series A financing led by [...]

By | February 17th, 2016|BioPharma & Healthcare, News, Pharmaceuticals|

What’s Next for Synthetic Biology in Biopharmaceuticals?

In the world of biopharmaceuticals, synthetic biology has quickly started to revolutionize drug discovery and design by providing a better overall molecular understanding of disease. Throughout the industry, biologists and engineers have come together over the past several years to [...]

By | February 2nd, 2016|BioPharma & Healthcare, News, Pharmaceuticals|

Harvest Capital Strategies Raises $245M Fund for Companies Utilizing Tools of Intrexon

Harvest Capital Strategies announced Tuesday that it has raised $245 million to specifically finance companies utilizing the synthetic biology tools of Intrexon Corporation. This is big news for Intrexon, whose subsidiaries and their genetically modified products have been prominent in [...]

From BIOtech to bioTECH: Meet Serial Entrepreneur Randal Kirk, CEO of Intrexon

There will be a lot of synthetic biologists at the upcoming conference, and a lot of entrepreneurs hoping to scale their company to greatness and riches (often these two are combined into the same person). It is, however, a difficult [...]

The Recipients of the 1st Annual Engineering Biology Awards Are…

The Annual SynBioBeta Engineering Biology Awards SynBioBeta has been supporting and reporting on the growth of synthetic biology as a field for many years now. From humble beginnings synthetic biology has reached the point where it underlies hundreds of companies, [...]

By | October 28th, 2015|BioPharma & Healthcare, News, Pharmaceuticals|